Kodiak Sciences KOD
$97.17 −$0.73 (-0.75%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $97.26 +0.09%
Open$97.00
Prev close$97.90
Day range$96.53 – $100.89
Volume693.1K
Market cap$6.35B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$0.00
Operating profit-$67.10M-7.6% YoY
Net profit-$66.22M-7.8% YoY
Diluted EPS-$1.05+9.5% YoY
Free cash flow-$45.85M-39.2% YoY
Operating cash flow-$43.87M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Return on equity-1,360.9%
Return on assets-115.4%
Return on invested capital-346.6%
Current ratio1.70
Liabilities / assets94.0%
Cash & investments$88.68M
Total debt$41.28M
Net cash (debt)$47.40M
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Operating Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expense | $67.10M | $66.84M | $59.78M | $234.39M | $57.45M |
| Selling and Admin Expenses | $8.79M | $10.76M | $11.23M | $52.02M | $11.96M |
| -General & Admin Expense | $8.79M | $10.76M | $11.23M | $52.02M | $11.96M |
| Research & Development | $58.30M | $56.08M | $48.55M | $182.37M | $45.49M |
| Operating Profit | -$67.10M | -$66.84M | -$59.78M | -$234.39M | -$57.45M |
| Net Non-Operating Interest Income (Expense) | $899,000.00 | $1.26M | $1.64M | $4.52M | $757,000.00 |
| Non-Operating Interest Income | $899,000.00 | $1.26M | $1.64M | $4.52M | $757,000.00 |
| Other Income (Expense) | -$24,000.00 | -$60,000.00 | -$22,000.00 | -$96,000.00 | -$40,000.00 |
| Other Non-Operating Income (Expenses) | -$24,000.00 | -$60,000.00 | -$22,000.00 | -$96,000.00 | -$40,000.00 |
| Pretax Profit | -$66.22M | -$65.64M | -$58.16M | -$229.97M | -$56.74M |
| Net Profit | -$66.22M | -$65.64M | -$58.16M | -$229.97M | -$56.74M |
| Profit from Continuing Operations | -$66.22M | -$65.64M | -$58.16M | -$229.97M | -$56.74M |
| Net Income to Parent Company | -$66.22M | -$65.64M | -$58.16M | -$229.97M | -$56.74M |
| Net Income to Common Stockholders | -$66.22M | -$65.64M | -$58.16M | -$229.97M | -$56.74M |
| Basic EPS | -$1.05 | -$1.05 | -$0.94 | -$4.32 | -$1.04 |
| Diluted EPS | -$1.05 | -$1.05 | -$0.94 | -$4.32 | -$1.04 |
| Non-Operating Interest Expense | – | – | – | $0.00 | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $209.41M | $256.81M | $306.01M | $351.53M | $351.53M |
| Total Current Assets | $92.89M | $131.36M | $175.26M | $214.82M | $214.82M |
| Cash and Cash Equivalents & Short-Term Investments | $88.68M | $125.90M | $169.53M | $209.86M | $209.86M |
| -Cash and Cash Equivalents | $88.68M | $125.90M | $169.53M | $209.86M | $209.86M |
| Other Current Assets | $4.21M | $5.46M | $5.73M | $4.95M | $4.95M |
| Total Non-Current Assets | $116.53M | $125.45M | $130.75M | $136.72M | $136.72M |
| Net PPE | $103.65M | $110.61M | $115.89M | $121.86M | $121.86M |
| -Gross PPE | $103.65M | $110.61M | $115.89M | $181.34M | $181.34M |
| Other Non-Current Assets | $12.88M | $14.85M | $14.86M | $14.85M | $14.85M |
| Total Liabilities | $196.84M | $195.72M | $193.91M | $194.15M | $194.15M |
| Total Current Liabilities | $54.74M | $52.77M | $49.57M | $45.53M | $45.53M |
| Payables | $16.86M | $12.64M | $11.34M | $12.86M | $12.86M |
| -Accounts Payable | $16.86M | $12.64M | $11.34M | $12.86M | $12.86M |
| Current Accrued Expenses | $32.59M | $30.32M | $26.57M | $20.61M | $20.61M |
| Short-Term Debt and Capital Lease Obligation | $5.29M | $9.81M | $11.66M | $12.06M | $12.06M |
| -Current Capital Lease Obligation | $5.29M | $9.81M | $11.66M | $12.06M | $12.06M |
| Total Non-Current Liabilities | $142.10M | $142.95M | $144.33M | $148.62M | $148.62M |
| Long Term Debt and Capital Lease Obligation | $41.28M | $42.95M | $44.33M | $47.12M | $47.12M |
| -Long Term Capital Lease Obligation | $41.28M | $42.95M | $44.33M | $47.12M | $47.12M |
| Other Non-Current Liabilities | $100.83M | $100.00M | $100.00M | $101.50M | $101.50M |
| Total Equity | $12.57M | $61.10M | $112.10M | $157.38M | $157.38M |
| Stockholders' Equity | $12.57M | $61.10M | $112.10M | $157.38M | $157.38M |
| Capital Stock | $6,000.00 | $6,000.00 | $6,000.00 | $6,000.00 | $6,000.00 |
| -Common Stock | $6,000.00 | $6,000.00 | $6,000.00 | $6,000.00 | $6,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $1.76B | $1.74B | $1.73B | $1.72B | $1.72B |
| Retained Earnings | -$1.75B | -$1.68B | -$1.62B | -$1.56B | -$1.56B |
| -Accumulated Depreciation | – | – | – | -$59.47M | -$59.47M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$43.87M | -$46.24M | -$40.01M | -$136.01M | -$39.38M |
| Net cash flow from continuing operations | -$43.87M | -$46.24M | -$40.01M | -$136.01M | -$39.38M |
| Net Income from Continuing Operations | -$66.22M | -$65.64M | -$58.16M | -$229.97M | -$56.74M |
| Depreciation & Depletion & Amortization | $4.86M | $6.19M | $6.34M | $26.32M | $6.52M |
| Change in Working Capital | $6.60M | $1.61M | -$346,000.00 | $6.85M | -$2.45M |
| -Change in Prepaid Assets | -$558,000.00 | $340,000.00 | -$975,000.00 | $609,000.00 | -$1.06M |
| -Change in Payables and Accrued Expense | $7.80M | $4.49M | $3.83M | $17.34M | $1.62M |
| -Change in Other Current Assets | $6,000.00 | $15,000.00 | -$8,000.00 | $59,000.00 | $6,000.00 |
| -Change in Other Current Liabilities | -$647,000.00 | -$3.24M | -$3.19M | -$11.17M | -$3.02M |
| Net cash flow from investing | -$1.98M | -$352,000.00 | -$942,000.00 | -$506,000.00 | -$43,000.00 |
| Net Cash Flow from Continuing Investing Activities | -$1.98M | -$352,000.00 | -$942,000.00 | -$506,000.00 | -$43,000.00 |
| Net PPE Purchase and Sale | -$1.98M | -$352,000.00 | -$942,000.00 | -$506,000.00 | -$43,000.00 |
| Financing Cash Flow | $6.38M | $2.96M | $619,000.00 | $178.30M | $177.25M |
| Net Cash Flow from Continuing Financing Activities | $6.38M | $2.96M | $619,000.00 | $178.30M | $177.25M |
| Proceeds from Stock Option Exercised | $6.49M | $2.86M | $922,000.00 | $5.34M | $4.29M |
| Net Other Financing Charges | $0.00 | $0.00 | -$303,000.00 | – | – |
| Ending Cash Balance | $92.62M | $132.09M | $175.71M | $216.05M | $216.05M |
| Net Change in Cash | -$39.46M | -$43.63M | -$40.33M | $41.79M | $137.82M |
| Beginning Cash Balance | $132.09M | $175.71M | $216.05M | $174.26M | $78.22M |
| Free Cash Flow | -$45.85M | -$46.59M | -$40.95M | -$136.51M | -$39.42M |
| Other Non-Cash Items | – | – | – | $20,000.00 | – |
| Net Investment Purchase and Sale | – | – | – | $0.00 | $0.00 |
| Net Common Stock Issuance | – | – | – | $172.96M | – |
No comments yet — be the first to weigh in on KOD.
Sign in to join the discussion.